Lexiscan

Background

NA

Approved applications

LEXISCAN® is a pharmacologic stress agent (PSA) for radionuclide myocardial perfusion imaging (MPI). This agent temporarily increases blood flow through the coronary arteries and is increasingly used by an aging “at risk” population who cannot exercise, but needs to mimic the increase in coronary blood flow in order to undergo radionuclide myocardial perfusion imaging (MPI) for the detection of coronary artery disease.

Therapeutic Area

Cardiovascular

Acquisition Date

Mar 2011

Marketer